CRITICAL REVIEWS IN IMMUNOLOGY, published by BEGELL HOUSE INC, is an essential journal in the field of immunology that has been contributing to the scientific discourse since 1980. With its ISSN 1040-8401 and E-ISSN 2162-6472, this journal provides a platform for critical analysis and comprehensive reviews that deepen understanding of immune responses and their implications in health and disease. Although currently categorized in the Q4 quartile for Immunology and Q3 for Immunology and Allergy, the journal's quality research and scholarly contributions are crucial for advancing knowledge within its fields—encompassing various aspects of innate and adaptive immunity. Researchers and professionals in immunology will find invaluable insights, aiding them in their quest for innovation and excellence, as the journal aims to foster interdisciplinary collaboration. While it does not operate on an open-access model, CRITICAL REVIEWS IN IMMUNOLOGY remains a significant resource for those dedicated to pushing the boundaries of immunology, with annual publications expected to last well into 2024 and beyond.

Journal of Inflammation Research, published by Dove Medical Press Ltd, is a premier open-access journal dedicated to advancing the field of immunology and allergy, with a particular focus on the biological mechanisms underlying inflammation. Since its inception in 2008, this journal has provided a vital platform for researchers to share their findings and foster collaboration within the global scientific community. With an impressive 2023 impact factor placing it in the Q2 category for both Immunology and Immunology and Allergy, the journal has consistently maintained its relevance and high academic standards, ranking #100 in Medicine (Immunology and Allergy) and #118 in Immunology (Immunology and Microbiology) according to Scopus metrics. The E-ISSN 1178-7031 allows for easy access to a plethora of pioneering research articles, reviews, and clinical studies that address contemporary issues in inflammation and immunity. As a leading resource for researchers, professionals, and students alike, Journal of Inflammation Research is committed to facilitating the dissemination of groundbreaking discoveries that contribute to improved therapeutic strategies and health outcomes.

Welcome to the European Journal of Immunology, a premier peer-reviewed journal dedicated to advancing the field of immunology and allergy research. Established in 1971 and published by Wiley, this esteemed journal has been consistently ranked in the top quartile (Q1) across its categories, highlighting its significant impact within the scientific community. With an impressive Scopus ranking, the journal occupies the 64th position in Immunology and Allergy and the 74th in the broader sector of Immunology and Microbiology, demonstrating its vital role in driving innovation and knowledge in immunological studies. The European Journal of Immunology publishes high-quality original research, comprehensive reviews, and insightful commentary, making it an indispensable resource for researchers, healthcare professionals, and students dedicated to understanding the complexities of the immune system. Although not an open-access journal, it offers various subscription options to ensure that institutions and individuals can access pivotal research that shapes the future of immunology.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, published by Mary Ann Liebert, Inc, stands out as a pivotal resource in the fields of immunology, virology, and cell biology, providing comprehensive insights into cytokine functions and their roles in immune responses. With ISSN 1079-9907 and E-ISSN 1557-7465, the journal aims to disseminate innovative research that advances our understanding of interferon and cytokine biology, a crucial aspect for developing therapeutic strategies against various diseases. Covering a broad scope of research from 1995 to 2024, it boasts a respectable impact factor within its category quartiles, ranking Q2 in Medicine (miscellaneous) and Q3 in the domains of Cell Biology, Immunology, and Virology as of 2023. While it does not provide open access options, the journal remains essential for academics, researchers, and professionals dedicated to exploring the complexities of immune signaling pathways and their implications for health and disease. The journal’s consistent contribution to scientific discourse underscores its importance in elevating query-driven studies to foster advancements in biomedical science.

CELL BIOCHEMISTRY AND FUNCTION is a prominent journal dedicated to disseminating high-quality research in the fields of biochemistry, cell biology, and clinical biochemistry. Published by Wiley, this journal has maintained an esteemed reputation since its inception in 1983, bridging decades of scientific advancements and contributions until 2024. With ISSN 0263-6484 and E-ISSN 1099-0844, it serves as a vital resource for researchers, professionals, and students. The journal is classified in quartiles Q2 and Q3 across various categories in the 2023 rankings, showcasing its impact and significance within the academic community. Highlighting essential studies in medicinal biochemistry and cellular functionalities, CELL BIOCHEMISTRY AND FUNCTION not only presents cutting-edge research but also encourages interdisciplinary collaboration, thereby advancing the understanding of biochemical processes that underlie living systems. With no open access currently available, readers are encouraged to access articles through institutional subscriptions or individual purchases, ensuring exclusive engagement with the latest scientific findings in this dynamic field.

FASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

NATURE IMMUNOLOGY is a premier academic journal published by NATURE PORTFOLIO, dedicated to advancing the field of immunology. With an impressive impact factor that reflects its esteemed position, this journal ranks in the top quartile (Q1) of renowned categories, including Immunology and Allergy. Serving as a crucial platform for researchers, professionals, and students, NATURE IMMUNOLOGY showcases cutting-edge research, comprehensive reviews, and insightful perspectives that drive innovation in immunological science. Based in the United Kingdom, this journal has been a vital contributor to the global discourse on immune responses and related diseases since its inception in 2000. Researchers can benefit from its rigorous peer-review process, ensuring that only high-quality studies are disseminated, thus enhancing their academic pursuits and practical applications. Explore the latest findings and trends within this flourishing discipline, making NATURE IMMUNOLOGY an essential resource for anyone engaged in the study of the immune system.

CYTOKINE & GROWTH FACTOR REVIEWS, published by Elsevier Science Ltd, serves as a premier platform for the dissemination of cutting-edge research in the fields of Biochemistry, Genetics and Molecular Biology, Endocrinology, and Immunology. With an impressive impact factor that places it in the Q1 category across multiple disciplines, the journal brings together high-quality reviews that critically evaluate recent advances in cytokine and growth factor biology. This ensures that researchers and professionals have access to valuable insights that enhance current knowledge and stimulate further investigation. Although it is not an open-access journal, its rigorous selection process and high ranking – including Rank #7 in Medicine: Endocrinology, Diabetes and Metabolism – underscore its significance within the scientific community. With its converged years of publication from 1996 to 2024, CYTOKINE & GROWTH FACTOR REVIEWS remains a crucial resource for students, researchers, and professionals alike, informing their work with comprehensive overviews of key topics in the dynamic interplay of growth factors and cytokines.

The American Journal of Reproductive Immunology, published by Wiley, is a leading peer-reviewed journal dedicated to advancing the field of reproductive immunology. Since its inception, the journal has been pivotal in fostering a deeper understanding of the immunological aspects of reproductive health, with a robust publication history spanning from 1980 to 2024. Positioned in the Q2 quartile for Immunology and Allergy and the Q1 quartile for both Obstetrics and Gynecology and Reproductive Medicine, it ranks impressively within its field, ensuring that cutting-edge research reaches a wide audience of professionals, researchers, and students. The journal's diverse scope encompasses critical studies that address the intricate interactions between the immune system and reproductive processes, making it an essential resource for those invested in this dynamic field. Although the journal is not open access, it remains committed to disseminating high-quality research, supported by a rigorous peer-review process that upholds the integrity of scientific inquiry.